GrahamIAtarDBorch-JohnsenKBoysenGBurellGCifkovaREuropean guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)Eur J Cardiovasc Prev Rehabil2007; 14 (Suppl 2):S1–S113.
2.
PyoralaKDe BackerGGrahamIPoole-WilsonPWoodD. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J1994; 15:1300–1331.
3.
KotsevaKWoodDDeBackerGDe BacquerDPyoralaKKeilUEUROASPIRE III: a survey on the lifestlye, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countriesEur J Cardiovasc Prev Rehabil2009 (in press).
4.
Hippisley-CoxJCouplandCVinogradovaYRobsonJMinhasRSheikhAPredicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ2008; 336:1475–1482.
5.
AssmannGCullenPSchulteH. Simple scoring scheme for calculating the risk of acute coronary events based on the 10 year follow-up of the prospective Cardiovascular Munster (PROCAM) Study. Circulation2002; 105:310–315.
6.
WoodwardMBrindlePTunstall-PedoeH. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart2007; 93:172–176.
7.
De BackerGAmbrosioniEBorch-JohnsenKBrotonsCCifkovaRDallongevilleJEuropean guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil2003; 10:S1–S10.
8.
ConroyRMPyoralaKFitzgeraldAPSansSMenottiADe BackerGEstimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J2003; 24:987–1003.
9.
AktasMKOzduranVPothierCELangRLauerMS. Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. JAMA2004; 292:1462–1468.
10.
CooneyMDudinaABacquerDDFitzgeraldAConroyRSansSHow much does HDL cholesterol add to risk estimation? A report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil2009; 16:304–314.
11.
CooneyMDudinaABacquerDDWilhelmsenLSansSMenottiAHDL cholesterol protects against cardiovascular disease in both genders, at al ages and at all levels of riskAtherosclerosis2009; 19: [Epub ahead of print].